In human breast cancer, oestrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) are well-established prognostic and predictive markers, and testing for them is now considered standard of care [1]. The gene discussed is ERBB2; the disease is breast cancer.